Serogroup 19 pneumococci containing both mef and erm macrolide resistance determinants in an American city

Philip Toltzis1, Michael Dul, Mary Ann O'Riordan

  • 1Department of Pediatrics, Rainbow Babies and Children's Hospital, University Hospitals of Cleveland, Case Western Reserve University School of Medicine, Cleveland, OH, USA. pxt2@case.edu

Abstract

Insights

Highly resistant pneumococci with macrolide resistance determinants are emerging in North America. These strains, linked to Asian variants, show resistance to vaccines and antibiotics in children.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • High incidence of macrolide-resistant pneumococci (mef/erm) in Asia.
  • Limited identification of mef/erm-containing pneumococci in North America previously.

Purpose of the Study:

  • Investigate the presence and characteristics of mef/erm-containing pneumococci in North America.
  • Determine the clonal relationship and clinical associations of these resistant strains.

Main Methods:

  • Polymerase chain reaction (PCR) to detect mef and erm genes in azithromycin-resistant pneumococci.
  • Pulsed field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) for clonal analysis.
  • Comparison of clinical characteristics of children colonized with mef/erm-positive vs. negative pneumococci.

Main Results:

  • 17.7% of children (17/221) were colonized with mef/erm-containing pneumococci.
  • These strains exhibited high-level azithromycin resistance (MIC > or =256 microg/mL) and co-resistance to other antibiotics.
  • Organisms were primarily serotype 19A/19F, related to the Taiwan-14 strain, and often found in children who received pneumococcal conjugate vaccine.

Conclusions:

  • Clonally related, drug-resistant serogroup 19 pneumococci are prevalent in a North American urban setting.
  • Current immunization strategies may not effectively contain the spread of these highly resistant strains.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...